quinazolines has been researched along with Animal Mammary Carcinoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, JL; Haas, M; Paul, R; Wang, C; Yeo, SK | 1 |
| Bode, A; Gill, SC; Grubbs, CJ; Iwata, KK; Juliana, MM; Lubet, RA; Nicastro, HL; Steele, VE; Szabo, E; Tucker, C | 1 |
| Cecil, DL; Disis, ML; Gad, E; Herendeen, DR; Lai, VP; Lubet, RA; O'Meara, MM; Park, KH; Treuting, PM | 1 |
| Abt, MA; Hill, EG; Yeh, ES | 1 |
| Bachawal, SV; Sylvester, PW; Wali, VB | 2 |
| Bode, AM; Carper, A; Cho, YY; Ericson, ME; Grubbs, CJ; Langfald, A; Li, J; Lubet, RA | 1 |
| Kennedy, KC; Qurollo, BA; Rose, BJ; Thamm, DH | 1 |
| Deng, X; Erfani, SF; Hemler, ME; Hoff, J; Jin, H; Kaetzel, DM; Li, Q; Novak, M; Rabinovitz, I; Sharma, C; Sonnenberg, A; Stipp, CS; Yang, H; Yang, XH; Yi, Y; Zhou, P | 1 |
| Chen, C; Chuang, TH; Liao, D; Liu, Y; Luo, Y; Markowitz, D; Reisfeld, RA; Xiang, R; Yang, J | 1 |
| Bally, MB; Chia, S; Denyssevych, T; Dragowska, WH; Gelmon, K; Masin, D; Wallis, AE; Warburton, C; Yan, H | 1 |
| Griffin, RJ; Ogawa, A; Song, CW | 1 |
12 other study(ies) available for quinazolines and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Improved efficacy of mitochondrial disrupting agents upon inhibition of autophagy in a mouse model of BRCA1-deficient breast cancer.
Topics: Animals; Autophagy; Autophagy-Related Proteins; Benzylamines; BRCA1 Protein; Cell Line, Tumor; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Intracellular Signaling Peptides and Proteins; Mammary Neoplasms, Animal; Metformin; Mice; Mitochondria; Models, Biological; Organelle Biogenesis; Oxidative Stress; Phosphorylation; Quinazolines; Substrate Specificity; TOR Serine-Threonine Kinases; Treatment Outcome | 2018 |
Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis.
Topics: Alkylating Agents; Animals; Blotting, Western; Dose-Response Relationship, Drug; Erlotinib Hydrochloride; Extracellular Signal-Regulated MAP Kinases; Female; Mammary Neoplasms, Animal; Methylnitrosourea; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Survival Rate; Tissue Distribution | 2013 |
A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease.
Topics: Adoptive Transfer; Animals; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Female; Insulin-Like Growth Factor Binding Protein 2; Lapatinib; Lymphocytes, Tumor-Infiltrating; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Neoplasm Invasiveness; Precancerous Conditions; Quinazolines; Receptor, ErbB-2; Receptor, IGF Type 1; T-Lymphocytes; Tetrahydronaphthalenes; Tumor Cells, Cultured; Vaccines, Subunit | 2013 |
Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors.
Topics: Animals; Antibodies, Monoclonal, Humanized; Apoptosis; Autophagy; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Mammary Neoplasms, Animal; Molecular Targeted Therapy; Protein Serine-Threonine Kinases; Quinazolines; Receptor, ErbB-2; Trastuzumab | 2015 |
Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromans; Culture Media, Serum-Free; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Mammary Neoplasms, Animal; Mice; Quinazolines; Signal Transduction; Trastuzumab; Vitamin E | 2010 |
Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Proliferation; Chromans; Erlotinib Hydrochloride; Female; Gefitinib; Mammary Neoplasms, Animal; Mice; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; STAT Transcription Factors; Vitamin E | 2010 |
Lapatinib, a preventive/therapeutic agent against mammary cancer, suppresses RTK-mediated signaling through multiple signaling pathways.
Topics: Animals; Apoptosis; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; ErbB Receptors; Female; Humans; Lapatinib; Mammary Neoplasms, Animal; Models, Chemical; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Signal Transduction | 2011 |
Epidermal growth factor enhances the malignant phenotype in canine mammary carcinoma cell lines.
Topics: Animals; Apoptosis; Cell Line, Tumor; Dog Diseases; Dogs; Epidermal Growth Factor; ErbB Receptors; Female; Mammary Neoplasms, Animal; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; Quinazolines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.
Topics: Animals; Butadienes; Cell Line, Tumor; Cell Movement; Epidermal Growth Factor; Female; Focal Adhesion Kinase 1; Humans; Integrin alpha6beta4; Lapatinib; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasm Metastasis; Nitriles; Phosphorylation; Quinazolines; Receptor, ErbB-2; Tetraspanin 24; Transendothelial and Transepithelial Migration | 2012 |
Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway.
Topics: Animals; Antigens, Ly; Apoptosis; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Communication; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Imidazoles; Macrophages; Mammary Neoplasms, Animal; Membrane Proteins; Mice; Nanog Homeobox Protein; Neoplastic Stem Cells; Octamer Transcription Factor-3; Oleanolic Acid; Quinazolines; RNA, Small Interfering; Signal Transduction; SOXB1 Transcription Factors; STAT3 Transcription Factor; Tyrphostins | 2013 |
Treatment of HER-2/neu overexpressing breast cancer xenograft models with trastuzumab (Herceptin) and gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fraction
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Membrane; Cell Survival; Coloring Agents; Dose-Response Relationship, Drug; Down-Regulation; ErbB Receptors; Female; Flow Cytometry; Gefitinib; Humans; Hypoxia; Mammary Neoplasms, Animal; Mice; Mice, SCID; Neoplasm Transplantation; Phosphorylation; Quinazolines; Receptor, ErbB-2; Subcellular Fractions; Tetrazolium Salts; Thiazoles; Time Factors; Trastuzumab | 2004 |
A novel drug to reduce tumor perfusion: antitumor effect alone and with hyperthermia.
Topics: Animals; Antineoplastic Agents; Blood Pressure; Carcinoma; Cell Line; Combined Modality Therapy; Hydrogen-Ion Concentration; Hyperthermia, Induced; Mammary Neoplasms, Animal; Mice; Neoplasm Transplantation; Perfusion; Piperazines; Quinazolines; Regional Blood Flow; Rubidium Radioisotopes; Time Factors; Vasoconstrictor Agents | 2000 |